4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001641172-25-002921
CEO and CFO bought 5,500 shares at $8.73 ($48,015)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2025-04-04 | Purchase | +5,500 | $8.73 | $48,015 | 5,558,002 | D: show line 1 in the form |
| Open-market purchases · 5,500 sh · avg $8.73 · $48,015 | |||||||
Loading xslF345X05/ownership.xml…